Labcorp Holdings (LH) Liabilities and Shareholders Equity (2009 - 2026)

Labcorp Holdings has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $19.1 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $19.1 billion, up 8.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.8 billion (up 3.5% YoY), and the FY2025 annual result was $18.4 billion, changed 0.07% from the prior year.
• Liabilities and Shareholders Equity came in at $19.1 billion for Q1 2026 at Labcorp Holdings, up from $18.4 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $20.7 billion in Q1 2022 to a low of $16.5 billion in Q1 2024.
• The 5-year median for Liabilities and Shareholders Equity is $18.4 billion (2024), against an average of $18.5 billion.
• Peak annual rise in Liabilities and Shareholders Equity reached 10.22% in 2024, while the deepest fall reached 18.16% in 2024.
• Labcorp Holdings' Liabilities and Shareholders Equity stood at $20.2 billion in 2022, then decreased by 17.02% to $16.7 billion in 2023, then grew by 9.89% to $18.4 billion in 2024, then climbed by 0.07% to $18.4 billion in 2025, then climbed by 3.78% to $19.1 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $19.1 billion (Q1 2026), $18.4 billion (Q4 2025), and $18.3 billion (Q3 2025), per Business Quant data.